Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-081405
Filing Date
2026-07-24
Accepted
2026-07-24 16:30:10
Documents
8
Period of Report
2026-07-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0299108-6k_chinasxt.htm 6-K 16002
2 FORM OF WARRANT ea029910801ex4-1.htm EX-4.1 91642
3 OPINION OF APPLEBY ea029910801ex5-1.htm EX-5.1 71855
4 FORM OF SECURITIES PURCHASE AGREEMENT ea029910801ex10-1.htm EX-10.1 504961
5 PLACEMENT AGENCY AGREEMENT ea029910801ex10-2.htm EX-10.2 92380
6 PRESS RELEASE DATED JULY 23, 2026 ea029910801ex99-1.htm EX-99.1 8557
7 GRAPHIC ea029910801_ex5-1img1.jpg GRAPHIC 12633
8 GRAPHIC ea029910801_ex99-1img1.jpg GRAPHIC 7257
  Complete submission text file 0001213900-26-081405.txt   814215
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China
Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 261201835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)